StonvexLoading…
StonvexStonvexStonvexCore line items from TNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.20B | $1.29B | $1.24B | $1.09B |
Operating Income | $68.30M | $114.30M | $138.60M | $87.20M |
Net Income | $43.80M | $83.70M | $109.50M | $66.30M |
EPS (Diluted) | $2.36 | $4.38 | $5.83 | $3.55 |
Total Assets | $1.27B | $1.19B | $1.11B | $1.09B |
Total Liabilities | $665.50M | $568.00M | $535.10M | $613.00M |
Cash & Equivalents | $106.40M | $99.80M | $117.10M | $77.40M |
Free Cash Flow OCF − CapEx | $43.30M | $68.80M | $165.60M | $-50.10M |
Shares Outstanding | 17.85M | 18.85M | 18.63M | 18.52M |